Page last updated: 2024-08-16

triazolam and terbinafine

triazolam has been researched along with terbinafine in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Neuvonen, PJ; Olkkola, KT; Varhe, A	1

Reviews

1 review(s) available for triazolam and terbinafine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for triazolam and terbinafine

Article	Year
Fluconazole, but not terbinafine, enhances the effects of triazolam by inhibiting its metabolism. British journal of clinical pharmacology, 1996, Volume: 41, Issue:4 Topics: Administration, Oral; Adult; Analysis of Variance; Antifungal Agents; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Fluconazole; Humans; Hypnotics and Sedatives; Male; Naphthalenes; Terbinafine; Triazolam	1996

Article

Year

Fluconazole, but not terbinafine, enhances the effects of triazolam by inhibiting its metabolism.

British journal of clinical pharmacology, 1996, Volume: 41, Issue:4

Topics: Administration, Oral; Adult; Analysis of Variance; Antifungal Agents; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Fluconazole; Humans; Hypnotics and Sedatives; Male; Naphthalenes; Terbinafine; Triazolam

1996

Other Studies

2 other study(ies) available for triazolam and terbinafine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004

Article

Year

QSAR model for drug human oral bioavailability.

Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004